NEPH
NEPHROS INC
Overview
NEPHROS INC is a Healthcare company operating in Medical Instruments & Supplies with a $34.2M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
18 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0812 Q&A exchanges
- Q4 FY2025Earnings2026-03-127 Q&A exchanges
- Q3 FY2025Earnings2025-11-0713 Q&A exchanges
- Q3 FY2024Earnings2024-11-0914 Q&A exchanges
- Q2 FY2024Earnings2024-08-105 Q&A exchanges
- Q1 FY2024Earnings2024-05-0915 Q&A exchanges
- Q4 FY2023Earnings2024-03-075 Q&A exchanges
- Q3 FY2023Earnings2023-11-104 Q&A exchanges
- Q2 FY2023Earnings2023-08-0910 Q&A exchanges
- Q1 FY2023Earnings2023-05-125 Q&A exchanges
- Q4 FY2022Earnings2023-03-0820 Q&A exchanges
- Q3 FY2022Earnings2022-11-0618 Q&A exchanges
- Q2 FY2022Earnings2022-08-1033 Q&A exchanges
- Q1 FY2022Earnings2022-05-0719 Q&A exchanges
- Q4 FY2021Earnings2022-02-2318 Q&A exchanges
- Q3 FY2021Earnings2021-11-0716 Q&A exchanges
- Q2 FY2021Earnings2021-08-074 Q&A exchanges
- Q1 FY2021Earnings2021-05-0941 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs ——Rev— vs ——EODHD
- Q1 FY20262026-05-12EPS$0.01 vs $0.04-75.0%Rev$5.2M vs ——EODHD
- Q4 FY20252026-03-04EPS$0.01 vs $-0.01+100.0%Rev$4.7M vs ——EODHD
- Q3 FY20252025-11-05EPS$0.03 vs $-0.02+100.0%Rev$4.8M vs ——EODHD
- Q2 FY20252025-08-06EPS$0.02 vs $-0.01+100.0%Rev$4.4M vs ——EODHD
- Q1 FY20252025-05-06EPS$0.05 vs $-0.01+100.0%Rev$4.9M vs ——EODHD
- Q4 FY20242025-03-04EPS$0.03 vs $-0.01+100.0%Rev$3.9M vs ——EODHD
- Q3 FY20242024-11-06EPS$0.02 vs $-0.02+100.0%Rev$3.5M vs ——EODHD
- Q2 FY20242024-08-07EPS$-0.03 vs $-0.01-100.0%Rev$3.3M vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.02 vs $-0.04+50.0%Rev$3.5M vs ——EODHD
- Q4 FY20232024-03-06EPS$-0.06 vs $-0.02-100.0%Rev$3.3M vs ——EODHD
- Q3 FY20232023-11-07EPS$-0.02 vs $-0.06+66.7%Rev$3.7M vs ——EODHD
- Q2 FY20232023-08-08EPS$-0.04 vs $-0.05+20.0%Rev$3.5M vs ——EODHD
- Q1 FY20232023-05-09EPS$-0.03 vs $-0.02-50.0%Rev$3.7M vs ——EODHD
- Q4 FY20222023-03-07EPS$-0.10 vs $-0.06-66.7%Rev$2.6M vs ——EODHD
- Q3 FY20222022-11-01EPS$-0.31 vs $-0.11-100.0%Rev$2.4M vs ——EODHD
- Q2 FY20222022-08-09EPS$-0.12 vs $-0.15+20.0%Rev$2.9M vs ——EODHD
- Q1 FY20222022-05-03EPS$-0.20 vs $-0.11-81.8%Rev$2.2M vs ——EODHD
- Q4 FY20212022-02-22EPS$-0.11 vs $-0.110.0%Rev$2.8M vs ——EODHD
- Q3 FY20212021-11-03EPS$-0.12 vs $-0.10-20.0%Rev$2.6M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | — | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $0.01 | $0.04 | -75.0% | $5.2M | — | — | EODHD |
| Q4 FY2025 | 2026-03-04 | $0.01 | $-0.01 | +100.0% | $4.7M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $0.03 | $-0.02 | +100.0% | $4.8M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $0.02 | $-0.01 | +100.0% | $4.4M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $0.05 | $-0.01 | +100.0% | $4.9M | — | — | EODHD |
| Q4 FY2024 | 2025-03-04 | $0.03 | $-0.01 | +100.0% | $3.9M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.02 | $-0.02 | +100.0% | $3.5M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.03 | $-0.01 | -100.0% | $3.3M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.02 | $-0.04 | +50.0% | $3.5M | — | — | EODHD |
| Q4 FY2023 | 2024-03-06 | $-0.06 | $-0.02 | -100.0% | $3.3M | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-0.02 | $-0.06 | +66.7% | $3.7M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-0.04 | $-0.05 | +20.0% | $3.5M | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $-0.03 | $-0.02 | -50.0% | $3.7M | — | — | EODHD |
| Q4 FY2022 | 2023-03-07 | $-0.10 | $-0.06 | -66.7% | $2.6M | — | — | EODHD |
| Q3 FY2022 | 2022-11-01 | $-0.31 | $-0.11 | -100.0% | $2.4M | — | — | EODHD |
| Q2 FY2022 | 2022-08-09 | $-0.12 | $-0.15 | +20.0% | $2.9M | — | — | EODHD |
| Q1 FY2022 | 2022-05-03 | $-0.20 | $-0.11 | -81.8% | $2.2M | — | — | EODHD |
| Q4 FY2021 | 2022-02-22 | $-0.11 | $-0.11 | 0.0% | $2.8M | — | — | EODHD |
| Q3 FY2021 | 2021-11-03 | $-0.12 | $-0.10 | -20.0% | $2.6M | — | — | EODHD |
Source: EODHD. NEPH reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks NEPH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 8/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.62 | $1.64 | -1.5% | +0.4% | -2.3% |
| Q4 FY2026 | $1.39 | $1.50 | -7.1% | +2.8% | +1.1% |
| Q3 FY2026 | $1.51 | $1.69 | -10.6% | +4.7% | +3.5% |
| Q2 FY2026 | $1.54 | $1.55 | -0.5% | -1.2% | -1.1% |
| Q1 FY2025 | $1.68 | $1.66 | +1.2% | -6.6% | -8.6% |
| Q4 FY2025 | $1.70 | $1.75 | -3.1% | -6.5% | -6.6% |
| Q3 FY2025 | $1.80 | $1.79 | +0.6% | -5.7% | -3.0% |
| Q2 FY2025 | $1.77 | $1.88 | -5.9% | -4.9% | -6.3% |
| Q1 FY2024 | $1.77 | $1.81 | -2.2% | -2.6% | -4.7% |
| Q4 FY2024 | $1.63 | $1.75 | -6.7% | -5.2% | -6.9% |
Guidance change history
Sample- Q1 FY2026Maintained2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Maintained2026-07-15
- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Maintained2025-13-15
- Q3 FY2025Suspended2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Robert R Banks JrCEO3 yr 1 mo10 callsCurrentSample
CEO since 2023 • 8/12 beats (67%) • last call held guidance Q1 FY2026
- Judy KrandelCFO2 yr 7 mo8 callsCurrentSample
CFO since 2023 • 4/12 beats (33%) • last call held guidance Q3 FY2026
- Andrew AstorCEO0 mo11 callsFormerSample
CEO since 2022 • 12/16 beats (75%) • last guidance raise Q2 FY2026
- Wesley S LoboChief Marketing Officer0 mono recorded callsFormerSample
OTHER_C_SUITE since 2022 • 10/16 beats (63%) • last guidance raise Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NEPH.
$ curl https://api.spokenalpha.com/v1/companies/NEPHFAQ
Frequently asked about NEPH
Where can I find NEPHROS INC's (NEPH) earnings call transcripts?
Spoken Alpha indexes NEPH's earnings call transcripts at https://spokenalpha.com/companies/NEPH. Each call links to attributed speakers and parsed analyst Q&A. NEPHROS INC's own investor relations page is at https://www.nephros.com/investors/.
When was NEPHROS INC's most recent earnings call?
NEPHROS INC (NEPH) held its most recent earnings call on 2026-05-08, covering fiscal Q1 2026.
What sector is NEPH in?
NEPHROS INC (NEPH) operates in the Healthcare sector (Medical Instruments & Supplies industry).